Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium

Cellular cardiomyoplasty is an attractive option for the treatment of severe heart failure. It is, however, still unclear and controversial which is the most promising cell source. Therefore, we investigated and examined the fate and functional impact of bone marrow (BM) cells and embryonic stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolossov, Eugen, Bostani, Toktam, Roell, Wilhelm, Breitbach, Martin, Pillekamp, Frank, Nygren, Jens M., Sasse, Philipp, Rubenchik, Olga, Fries, Jochen W. U., Wenzel, Daniela, Geisen, Caroline, Xia, Ying, Lu, Zhongju, Duan, Yaqi, Kettenhofen, Ralf, Jovinge, Stefan, Bloch, Wilhelm, Bohlen, Heribert, Welz, Armin, Hescheler, Juergen, Jacobsen, Sten Eirik, Fleischmann, Bernd K.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2006
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118112/
https://www.ncbi.nlm.nih.gov/pubmed/16954371
http://dx.doi.org/10.1084/jem.20061469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118112/
https://www.ncbi.nlm.nih.gov/pubmed/16954371
http://dx.doi.org/10.1084/jem.20061469

Ejemplares similares